Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Quantum Dot Manufacturer and Biomedical Nanotech Company Technology Alliance Targets Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression.
Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression are the four theranostic clinical research targets of the new Quantum Materials Corporation (OTC: QTMM) and NanoAxis LLC Technology Alliance. The Alliance will develop new nanomedicine products for both diagnostic and pharmaceutical applications incorporating quantum dot technology.
http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2011/09/21/prweb8794822.DTL
Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression are the four theranostic clinical research targets of the new Quantum Materials Corporation (OTC: QTMM) and NanoAxis LLC Technology Alliance. The Alliance will develop new nanomedicine products for both diagnostic and pharmaceutical applications incorporating quantum dot technology.
http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2011/09/21/prweb8794822.DTL